Sort
11,323 grants matching “glioblastoma”
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$689,091Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2023 · CA
Defining the role of cytomegalovirus in glioblastoma therapies
$688,910Sean Edward Lawler · Brown University · R01 · FY2022 · CA
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
$688,403Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2018 · CA
Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma
$688,395Constantinos George Hadjipanayis · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Development of Natural Product Leads as Anticancer Therapeutics
$687,723John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mapping Immune Contexture and Crosstalk with Tumor Cells At GBM Margin
$687,394Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS
Dissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment Outcomes
$687,279Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2025 · NS
Lentiviral Vectors to Model Human Gliomas in Mice
$687,125Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2011 · HL
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$686,605Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Imaging and Targeted Auger Radiotherapy of High-Grade Glioma
$686,125Joel Richard Garbow · Washington University · R01 · FY2021 · EB
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
$685,920Carol A Kruse · University Of California Los Angeles · R01 · FY2012 · CA
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
$684,353Christopher Chad Quarles · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Evolution of gliomas during treatment and resistance
$683,652Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Evolution of gliomas during treatment and resistance
$683,652Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Mapping Immune Contexture and Crosstalk with Tumor Cells At GBM Margin
$683,211Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
Using implantable microdevices for deep phenotyping of multiple drug responses in brain tumor patients
$682,907Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2024 · CA
Image-guided cancer therapy using heat activatable CAR T cells
$682,800Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2022 · EB
Artificial Intelligence Boosted Evolution and Detection of Genetically Encoded Reporters for In Vivo Imaging
$682,727Christian T Farrar · Massachusetts General Hospital · R01 · FY2022 · EB
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$682,689David A. Hafler · Yale University · R01 · FY2025 · CA
Understanding and Eliminating Oncogenic EGFR Signaling in Malignant Glioma
$682,666Alain Charest · Tufts Medical Center · U01 · FY2010 · CA
Genetic evolution of glioblastomas during radiation and temozolomide therapy
$682,620Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2018 · CA
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
$682,371Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2020 · CA
Brain Tumors - Immunological and Biological Studies
$682,341Darell D Bigner · Duke University · R37 · FY2011 · CA
Comparison of convection enhanced delivery systems in a randomized controlled clinical study of recurrent Grade 3-4 glioma patients
$682,122Vasiliy Abramov · Creosalus, Inc. · R44 · FY2025 · CA
Brain Tumors - Immunological and Biological Studies
$681,848Darell D Bigner · Duke University · R37 · FY2012 · CA